When.com Web Search

  1. Ads

    related to: a549 cells media

Search results

  1. Results From The WOW.Com Content Network
  2. A549 cell - Wikipedia

    en.wikipedia.org/wiki/A549_cell

    A549 cells are adenocarcinomic human alveolar basal epithelial cells, and constitute a cell line that was first developed in 1972 by D. J. Giard, et al. through the removal and culturing of cancerous lung tissue in the explanted tumor of a 58-year-old caucasian male. [1]

  3. Immortalised cell line - Wikipedia

    en.wikipedia.org/wiki/Immortalised_cell_line

    An immortalised cell line is a population of cells from a multicellular organism that would normally not proliferate indefinitely but, due to mutation, have evaded normal cellular senescence and instead can keep undergoing division. The cells can therefore be grown for prolonged periods in vitro. The mutations required for immortality can occur ...

  4. Category:Epithelial cells - Wikipedia

    en.wikipedia.org/wiki/Category:Epithelial_cells

    Main page; Contents; Current events; Random article; About Wikipedia; Contact us

  5. SUCNR1 - Wikipedia

    en.wikipedia.org/wiki/SUCNR1

    C) A549 cells treated with a short hairpin RNA that knocked down their levels of SUCNR1 had significantly reduced migration responses to succinate. D) A549 cells treated with succinate showed increases in SNAI1, a transcription factor that promotes EMT. E) Metformin (which is an inhibitor of EMT [72]) abolished the migration responses of A549 ...

  6. A549 - Wikipedia

    en.wikipedia.org/wiki/A549

    A549 may refer to: A549 (cell line), a carcinomic human alveolar basal epithelial cell; A549 road (Wales), a road in Great Britain This page was last edited on 27 ...

  7. Jelly blubber - Wikipedia

    en.wikipedia.org/wiki/Jelly_blubber

    The cnidocytes of C. mosaicus hold venom which may have apoptopic effects on A549 cells, the same cells linked to pulmonary adenocarcinoma, a common form of lung cancer. [18] Further study and isolation of these cnidocytes may lead to anticancer innovations. [18]